Safety and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Given With and Without AS03 or MF59 Adjuvants in Healthy Adults

Overview of attention for article published in Clinical Infectious Diseases, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 36,457 followers.

A phase I, randomized, blinded trial evaluated the safety and immunogenicity of a monovalent inactivated #influenzaA/H5N8 virus vaccine, given with and without AS03 or MF59 adjuvants. #VaccineResearch Read more in @CIDJournal: 🩺 https://t.co/47YtUg8wL1 …

8-29-2022: Iowa City, Iowa: Compliance by humans for the influenza A(H5N8) vaccine will probably be very low: https://t.co/hWp7e8X0oU https://t.co/VKwo4PtwyL https://t.co/Vby206YEpY https://t.co/s1EpUfNcmi https://t.co/mstaedn4qj https://t.co/jO9OuALJC…

Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults ✅ Just Accepted 🔗 https://t.co/7CqxigTVIx https://t.co/Mfj1gsdpcN

Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults https://t.co/LlG7zBbZUu

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.